Influence of dopaminergic anti-Parkinsonian agents on inflammatory reactions in rats.
Hirschelmann
R
R
Thong
N T
NT
D000818:Animals; D000978:Antiparkinson Agents / Q000494:pharmacology*; D001169:Arthritis, Experimental; D001545:Benserazide / Q000494:pharmacology; D001971:Bromocriptine / Q000494:pharmacology; D002351:Carrageenan; D015259:Dopamine Agents / Q000494:pharmacology*; D004487:Edema / Q000139:chemically induced / Q000517:prevention & control; D005070:Evans Blue; D005260:Female; D007249:Inflammation / Q000473:pathology*; D007980:Levodopa / Q000494:pharmacology; D051381:Rats; D017208:Rats, Wistar
D000978:Antiparkinson Agents; D015259:Dopamine Agents; D001971:Bromocriptine; D005070:Evans Blue; D007980:Levodopa; D001545:Benserazide; D002351:Carrageenan